RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 111 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $989,305 | +40.7% | 43,154 | +1.2% | 0.00% | – |
| Q2 2023 | $703,350 | +130.3% | 42,653 | +149.2% | 0.00% | – |
| Q1 2023 | $305,403 | -29.1% | 17,119 | +15.7% | 0.00% | – |
| Q4 2022 | $430,859 | +80.3% | 14,796 | +51.5% | 0.00% | – |
| Q3 2022 | $239,000 | +368.6% | 9,768 | -20.2% | 0.00% | – |
| Q2 2022 | $51,000 | -66.7% | 12,247 | -7.7% | 0.00% | – |
| Q1 2022 | $153,000 | +15.9% | 13,263 | 0.0% | 0.00% | – |
| Q4 2021 | $132,000 | -23.7% | 13,263 | 0.0% | 0.00% | – |
| Q3 2021 | $173,000 | +36.2% | 13,263 | +105.6% | 0.00% | – |
| Q2 2021 | $127,000 | -7.3% | 6,452 | -0.1% | 0.00% | – |
| Q1 2021 | $137,000 | -9.9% | 6,456 | +26.1% | 0.00% | – |
| Q4 2020 | $152,000 | +35.7% | 5,121 | -1.1% | 0.00% | – |
| Q3 2020 | $112,000 | -24.3% | 5,177 | -22.0% | 0.00% | – |
| Q2 2020 | $148,000 | +74.1% | 6,640 | +13.7% | 0.00% | – |
| Q1 2020 | $85,000 | -48.2% | 5,841 | -18.2% | 0.00% | – |
| Q4 2019 | $164,000 | +80.2% | 7,144 | +69.4% | 0.00% | – |
| Q3 2019 | $91,000 | -2.2% | 4,217 | 0.0% | 0.00% | – |
| Q2 2019 | $93,000 | +17.7% | 4,217 | +47.7% | 0.00% | – |
| Q1 2019 | $79,000 | +11.3% | 2,855 | +6.7% | 0.00% | – |
| Q4 2018 | $71,000 | -9.0% | 2,675 | 0.0% | 0.00% | – |
| Q3 2018 | $78,000 | +36.8% | 2,675 | +46.6% | 0.00% | – |
| Q2 2018 | $57,000 | +96.6% | 1,825 | +26.6% | 0.00% | – |
| Q1 2018 | $29,000 | -31.0% | 1,442 | 0.0% | 0.00% | – |
| Q4 2017 | $42,000 | – | 1,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |